A randomised controlled trial of a safer sex intervention delivered through mobile phone messaging

Not Applicable

Completed

• Conditions: Topic: Infectious Diseases; Subtopic: Infectious Diseases; Disease: Infectious Diseases and Microbiology; Infections and Infestations; Sexually transmitted infections

• Registration Number: ISRCTN64390461
• Lead Sponsor: ondon School of Hygiene and Tropical Medicine

Brief Summary

2020 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/32152156 protocol (added 11/03/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36170988/ (added 29/09/2022) 2023 Results article in https://doi.org/10.1136/bmjopen-2023-072701 Qualitative results (added 26/10/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-03-17
• Study Completion: 2020-05-06
• Last Update Posted: 6 November 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 6248

Inclusion Criteria

1. Aged 16 to 24 inclusive
2. Received a positive chlamydia or gonorrhoea test result or have been diagnosed with NSU in the last 2 weeks
3. Own a personal mobile phone
4. Able to provide informed consent

Exclusion Criteria

Known to be a sexual partner of someone already recruited to the trial.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Cumulative incidence of Chlamydia and gonorrhoea infection at one year assessed by NAAT (nucleic acid amplification test) tests: urine for men with pharyngeal and anal swabs for MSM (men who have sex with men) and self-taken vulvo-vaginal swab for women.